Discovery of a low order drug-cell response surface for applications in personalized medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of a low order drug-cell response surface for applications in personalized medicine

Published:2014-11-26 Issue:6 Volume:11 Page:065003
ISSN:1478-3975
Container-title:Physical Biology
language:
Short-container-title:Phys. Biol.

Author:

Ding Xianting,Liu Wenjia,Weiss Andrea,Li Yiyang,Wong Ieong,Griffioen Arjan W,van den Bergh Hubert,Xu Hongquan,Nowak-Sliwinska Patrycja,Ho Chih-Ming

Funder

National Science and Technology Major Projects for "Major New Drugs Innovation and Development"

National Natural Science Foundation of China

Publisher

IOP Publishing

Subject

Cell Biology,Molecular Biology,Structural Biology,Biophysics

Link

http://stacks.iop.org/1478-3975/11/i=6/a=065003/pdf

Reference26 articles.

1. Drugs, their targets and the nature and number of drug targets

2. Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics

3. Chemokines and Glial Cells: A Complex Network in the Central Nervous System

4. The Dendritic Cell System and its Role in Immunogenicity

5. A novel genetic system to detect protein–protein interactions

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selectively cross-linked hydrogel-based cocktail drug delivery micro-chip for colon cancer combinatorial drug screening using AI-CSR platform for precision medicine;Lab on a Chip;2024

2. HDACIs and TKIs combinations and their liposomal delivery for cancer treatment;Journal of Controlled Release;2023-06

3. In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal Carcinoma;Advanced Therapeutics;2023-04-19

4. Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer;Cellular and Molecular Life Sciences;2023-03

5. Splice‐switch oligonucleotide‐based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC ‐driven hepatocellular carcinoma;Bioengineering & Translational Medicine;2022-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3